BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11803068)

  • 21. Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.
    de la Poza F; Calvo-Pinilla E; López-Gil E; Marín-López A; Mateos F; Castillo-Olivares J; Lorenzo G; Ortego J
    PLoS One; 2013; 8(7):e70197. PubMed ID: 23894615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
    Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
    Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR
    O'Kennedy MM; Coetzee P; Koekemoer O; du Plessis L; Lourens CW; Kwezi L; du Preez I; Mamputha S; Mokoena NB; Rutkowska DA; Verschoor JA; Lemmer Y
    Vaccine; 2022 Aug; 40(35):5160-5169. PubMed ID: 35902279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horsesickness virus serotypes.
    Potgieter AC; Cloete M; Pretorius PJ; van Dijk AA
    J Gen Virol; 2003 May; 84(Pt 5):1317-1326. PubMed ID: 12692299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
    O'Kennedy MM; Roth R; Ebersohn K; du Plessis LH; Mamputha S; Rutkowska DA; du Preez I; Verschoor JA; Lemmer Y
    PLoS One; 2024; 19(4):e0301340. PubMed ID: 38625924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.
    Vreede FT; Huismans H
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3629-33. PubMed ID: 7996157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.
    Castillo-Olivares J; Calvo-Pinilla E; Casanova I; Bachanek-Bankowska K; Chiam R; Maan S; Nieto JM; Ortego J; Mertens PP
    PLoS One; 2011 Jan; 6(1):e16503. PubMed ID: 21298069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.
    Roy P; Sutton G
    Arch Virol Suppl; 1998; 14():177-202. PubMed ID: 9785506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning, sequencing and expression of the gene that encodes the major neutralisation-specific antigen of African horsesickness virus serotype 9.
    Venter M; Napier G; Huismans H
    J Virol Methods; 2000 Apr; 86(1):41-53. PubMed ID: 10713375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.
    Burrage TG; Trevejo R; Stone-Marschat M; Laegreid WW
    Virology; 1993 Oct; 196(2):799-803. PubMed ID: 7690505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
    Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
    Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
    von Teichman BF; Dungu B; Smit TK
    Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic markers in early stages of African horse sickness virus infection.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Clin Microbiol; 1997 Feb; 35(2):531-5. PubMed ID: 9003637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides.
    Martínez-Torrecuadrada JL; Langeveld JPM; Meloen RH; Casal JI
    J Gen Virol; 2001 Oct; 82(Pt 10):2415-2424. PubMed ID: 11562535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
    Martínez-Torrecuadrada JL; Casal JI
    Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
    Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
    J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baculovirus expression of non-structural protein NS2 and core protein VP7 of African horsesickness virus serotype 3 and their use as antigens in an indirect ELISA.
    Bremer CW; du Plessis DH; van Dijk AA
    J Virol Methods; 1994 Jul; 48(2-3):245-56. PubMed ID: 7989441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
    Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
    Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.
    Bentley L; Fehrsen J; Jordaan F; Huismans H; du Plessis DH
    J Gen Virol; 2000 Apr; 81(Pt 4):993-1000. PubMed ID: 10725425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens.
    Pradhan SN; Prince PR; Madhumathi J; Roy P; Narayanan RB; Antony U
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):293-301. PubMed ID: 22795186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.